Substance

RESLIZUMAB

Global reference: every product and company linked to this substance.

CEP-38072 · CINQAIR · DCP 835 · DCP-835 · reslizumab [INN] · RESLIZUMAB [USAN] · Reslizumab [WHO-DD] · SCH-55700 · SCH55700

Revenue by product (0)

No revenue reported for this substance in loaded filings.

A figure belongs to the product it was reported for. It is never summed across companies or across a company's products, so one substance in three products shows three figures.

Products containing this substance (1)

  • CINQAIR · TEVA PHARMACEUTICAL INDUSTRIES LIMITED AMERICAN DEPOSITARY SHARES

Companies holding this asset (1)